Xtant Medical Holdings Inc (XTNT)
0.4147
0.00 (0.00%)
USD |
NYAM |
Nov 21, 16:00
0.4107
0.00 (0.00%)
After-Hours: 20:00
Xtant Medical Holdings Revenue (Quarterly): 27.94M for Sept. 30, 2024
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 27.94M |
| June 30, 2024 | 29.94M |
| March 31, 2024 | 27.87M |
| December 31, 2023 | 28.11M |
| September 30, 2023 | 25.02M |
| June 30, 2023 | 20.23M |
| March 31, 2023 | 17.94M |
| December 31, 2022 | 15.27M |
| September 30, 2022 | 14.46M |
| June 30, 2022 | 15.28M |
| March 31, 2022 | 12.96M |
| December 31, 2021 | 13.97M |
| September 30, 2021 | 13.78M |
| June 30, 2021 | 14.98M |
| March 31, 2021 | 12.54M |
| December 31, 2020 | 14.02M |
| September 30, 2020 | 14.02M |
| June 30, 2020 | 10.53M |
| March 31, 2020 | 14.78M |
| December 31, 2019 | 16.96M |
| September 30, 2019 | 15.72M |
| June 30, 2019 | 15.27M |
| March 31, 2019 | 16.73M |
| December 31, 2018 | 18.26M |
| September 30, 2018 | 17.27M |
| Date | Value |
|---|---|
| June 30, 2018 | 18.74M |
| March 31, 2018 | 17.93M |
| December 31, 2017 | 19.33M |
| September 30, 2017 | 19.79M |
| June 30, 2017 | 21.41M |
| March 31, 2017 | 22.08M |
| December 31, 2016 | 24.47M |
| September 30, 2016 | 23.09M |
| June 30, 2016 | 21.46M |
| March 31, 2016 | 20.98M |
| December 31, 2015 | 22.26M |
| September 30, 2015 | 17.69M |
| June 30, 2015 | 9.893M |
| March 31, 2015 | 9.503M |
| December 31, 2014 | 9.081M |
| September 30, 2014 | 8.454M |
| June 30, 2014 | 8.884M |
| March 31, 2014 | 8.913M |
| December 31, 2013 | 8.258M |
| September 30, 2013 | 7.93M |
| June 30, 2013 | 8.267M |
| March 31, 2013 | 8.619M |
| December 31, 2012 | 8.122M |
| September 30, 2012 | 8.880M |
| June 30, 2012 | 8.208M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
10.53M
Minimum
Jun 2020
29.94M
Maximum
Jun 2024
18.03M
Average
15.12M
Median
Revenue (Quarterly) Benchmarks
| Plus Therapeutics Inc | -- |
| Perspective Therapeutics Inc | -- |
| Retractable Technologies Inc | 10.35M |
| InfuSystems Holdings Inc | 35.32M |
| Catheter Precision Inc | 0.096M |
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | -5.024M |
| Total Expenses (Quarterly) | 31.71M |
| EPS Diluted (Quarterly) | -0.04 |
| Enterprise Value | 85.83M |
| Gross Profit Margin (Quarterly) | 58.37% |
| Profit Margin (Quarterly) | -17.98% |
| Earnings Yield | -31.35% |
| Normalized Earnings Yield | -32.81 |